NIDDM and IR in Combination Therapy for CHC

NCT00687999 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

400

Enrollment

OTHER

Sponsor class

Conditions

Chronic Hepatitis C
Insulin Resistance

Interventions

DRUG: pegylated interferon alpha and ribavirin

Sponsor

Kaohsiung Medical University Chung-Ho Memorial Hospital

Collaborators

[object Object]